Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-30 @ 12:55 AM
Study NCT ID:
NCT01091103
Status:
COMPLETED
Last Update Posted:
2018-10-23
First Post:
2010-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-18
Start Date Type:
ACTUAL
Primary Completion Date:
2012-02-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-19
First Submit QC Date:
None
Study First Post Date:
2010-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-10
Results First Submit QC Date:
None
Results First Post Date:
2014-11-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-10-23
Last Update Post Date Type:
ACTUAL